Close
The page header's logo
Help
Login
Staff Login
Register
FR
0
Selected 
Invert selection
Deselect all
Deselect all
 Add to Cart
 Click here to refresh results
 Click here to refresh results
Go to Login page
 Hide details
doctype icon
Conceptually similar
3rd major COVID-19 vaccine shown to be effective
play button
CP112067360 | 3rd major COVID-19 vaccine shown to be effective 
What to know about Johnson & Johnson's COVID-19 vaccine
play button
CP119565630 | What to know about Johnson & Johnson's COVID-19 vaccine 
Nearly one million COVID-19 vaccine doses arriving in Canada this week: Anand
play button
CP119321831 | Nearly one million COVID-19 vaccine doses arriving in Canada this week: Anand 
All approved COVID-19 vaccines safe, effective: Trudeau
play button
CP122770871 | All approved COVID-19 vaccines safe, effective: Trudeau 
Manitoba approves different second dose after AstraZeneca COVID-19 vaccine
play button
CP124342421 | Manitoba approves different second dose after AstraZeneca COVID-19 vaccine 
Ontario to offer vaccines to residents 75 and older
play button
CP120269571 | Ontario to offer vaccines to residents 75 and older 
Ghana 1st nation to receive vaccines from COVAX
play button
CP118800860 | Ghana 1st nation to receive vaccines from COVAX 
Newly eligible people receive Oxford-AstraZeneca vaccine
play button
CP121946460 | Newly eligible people receive Oxford-AstraZeneca vaccine 
Feds defend not donating Pfizer, Moderna vaccines to poor countries
play button
CP126934421 | Feds defend not donating Pfizer, Moderna vaccines to poor countries 
Trump: Vaccine trials on track to combat pandemic
play button
CP21197135 | Trump: Vaccine trials on track to combat pandemic 
Action button

Trial participants react to news on COVID vaccine

Three participants in the AstraZeneca clinical trial for the COVID-19 vaccine say news that the vaccine produced by Pfizer Inc. may be 90% effective is encouraging and they are all a team, no matter who finishes first. (Nov. 10) 
Actions
 Add to collection
 Add to cart
Information
Source name: 
The Associated Press
Unique identifier: CP111599521 
Legacy Identifier: fd272c4f736649edb344f1bad53aab18 
Type: Video 
Duration: 50s 
Dimensions: 1920px × 1080px     62.19 MB 
Usage rights: Digital platform use only. Broadcast rights and editing of content prohibited. 
Create Date: 11/10/2020 2:57:39 PM 
Display aspect ratio: 16:9